Career history of Gregory C. Williams
Former positions of Gregory C. Williams
| Companies | Position | Start | End |
|---|---|---|---|
| ELOXX PHARMACEUTICALS, INC. | Director/Board Member | 29/02/2020 | 01/04/2021 |
| Chief Executive Officer | 29/02/2020 | 01/04/2021 | |
| Chief Operating Officer | 25/06/2018 | 29/02/2020 | |
| Chief Tech/Sci/R&D Officer | 25/06/2018 | 01/09/2019 | |
| RADIUS HEALTH, INC. | Corporate Officer/Principal | 09/01/2014 | 25/05/2018 |
| THE MEDICINES COMPANY | Chief Tech/Sci/R&D Officer | 01/01/2006 | 01/01/2013 |
| General Counsel | 01/01/2006 | 01/01/2013 | |
| NPS PHARMACEUTICALS, INC. | Compliance Officer | 01/01/2004 | 01/01/2006 |
| General Counsel | 01/01/2004 | 01/01/2006 |
Training of Gregory C. Williams
| Rutgers State University of New Jersey | Doctorate Degree |
| Cornell University | Masters Business Admin |
Statistics
International
| United States | 7 |
Operational
| Chief Tech/Sci/R&D Officer | 2 |
| General Counsel | 2 |
| Corporate Officer/Principal | 1 |
Sectoral
| Health Technology | 5 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| ELOXX PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 3 |
|---|---|
Radius Health, Inc.
 Radius Health, Inc. BiotechnologyHealth Technology Radius Health, Inc. is a biopharmaceutical company, which engages in developing and commercializing endocrine therapeutics in the areas of osteoporosis and oncology. The company’s lead product, Abaloparatide-SC, reduces fracture risk in postmenopausal women with osteoporosis. Its pipeline also includes the abaloparatide transdermal patch for potential use in osteoporosis, and RAD1901 for potential use in hormone-driven, or hormone-resistant, metastatic breast cancer, and vasomotor symptoms in postmenopausal women. The company was founded by John Katzenellenbogen, Stavros C. Manolagas, Michael Rosenblatt, and John T. Potts on October 3, 2003 and is headquartered in Boston, MA. | Health Technology |
The Medicines Co.
 The Medicines Co. Pharmaceuticals: MajorHealth Technology The Medicines Co. is a biopharmaceutical company, which focuses on saving lives, alleviating suffering and contributing to the economics of healthcare by focusing on acute and intensive care hospitals worldwide. The firm markets its brands Angiomax, Cleviprex, injectable emulsion, Ionsys, Kengreal, Minocin for injection, and Orbactiv. The company was founded by Clive A. Meanwell, Helmut Giersiefen, John W. Villiger and T. Scott Johnson on July 31, 1996 and is headquartered in Parsippany, NJ. | Health Technology |
NPS Pharmaceuticals, Inc.
 NPS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NPS Pharmaceuticals, Inc. developed drugs for bone and mineral disorders. It also developed Natpara for the treatment of adult hypoparathyroidism. The company was founded by Hunter Jackson and Thomas N. Parks on October 22, 1986 and is headquartered in Bedminster, NJ. | Health Technology |
- Stock Market
- Insiders
- Gregory C. Williams
- Experience
